Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma

ClinicalTrials.gov ID: NCT00107380

Public ClinicalTrials.gov record NCT00107380. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 10:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Iodine-131-Labeled Monoclonal Anti-B1 Antibody (I-131 Tositumomab) in Combination With Cyclophosphamide, Doxorubicin, Vincristine, Prednisone and Rituximab Therapy for Patients ≥ Age 60 With Advanced Stage Diffuse Large B-Cell NHL: A Phase II Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Radiolabeled monoclonal antibodies, such as iodine I 131 tositumomab, can find cancer cells and carry cancer-killing substances to them without harming normal cells. Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Drugs used in chemotherapy, such as cyclophosphamide, doxorubicin, vincristine, and prednisone, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving a radiolabeled monoclonal antibody together with rituximab and combination chemotherapy may kill more cancer cells. PURPOSE: This phase II trial is studying how well giving iodine I 131 tositumomab together with rituximab and combination chemotherapy works in treating older patients with stage II, stage III, or stage IV B-cell non-Hodgkin's lymphoma.

Study identification

NCT ID
NCT00107380
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
SWOG Cancer Research Network
Network
Enrollment
86 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2005 (Type not available)
Primary completion
Nov 2013 (Actual)
Completion
Dec 2015 (Actual)
Last update posted
Mar 7, 2016

2005 – 2015

United States locations

U.S. sites
78
U.S. states
16
U.S. cities
49
Facility City State ZIP Site status
Alaska Regional Hospital Cancer Center Anchorage Alaska 99508 —
Arizona Cancer Center at University of Arizona Health Sciences Center Tucson Arizona 85724-5024 —
City of Hope Comprehensive Cancer Center Duarte California 91010-3000 —
Piedmont Hospital Atlanta Georgia 30309 —
Northside Hospital Cancer Center Atlanta Georgia 30342-1611 —
Saint Joseph's Hospital of Atlanta Atlanta Georgia 30342-1701 —
CCOP - Atlanta Regional Atlanta Georgia 30342 —
WellStar Cobb Hospital Austell Georgia 30106 —
Charles B. Eberhart Cancer Center at DeKalb Medical Center Decatur Georgia 30033 —
Gwinnett Medical Center Lawrenceville Georgia 30045 —
Kennestone Cancer Center at Wellstar Kennestone Hospital Marietta Georgia 30060 —
Southern Regional Medical Center Riverdale Georgia 30274-2600 —
Harbin Clinic Cancer Center - Medical Oncology Rome Georgia 30165 —
Saint Anthony's Hospital at Saint Anthony's Health Center Alton Illinois 62002 —
Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood Illinois 60153 —
Good Samaritan Regional Health Center Mount Vernon Illinois 62864 —
St. Francis Hospital and Health Centers - Beech Grove Campus Beech Grove Indiana 46107 —
Reid Hospital & Health Care Services Richmond Indiana 47374 —
Cotton-O'Neil Cancer Center Topeka Kansas 66606 —
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109-0942 —
Saint Francis Medical Center Cape Girardeau Missouri 63703 —
Midwest Hematology Oncology Group, Incorporated St Louis Missouri 63109 —
CCOP - St. Louis-Cape Girardeau St Louis Missouri 63141 —
David C. Pratt Cancer Center at St. John's Mercy St Louis Missouri 63141 —
CCOP - Montana Cancer Consortium Billings Montana 59101 —
Hematology-Oncology Centers of the Northern Rockies - Billings Billings Montana 59101 —
Northern Rockies Radiation Oncology Center Billings Montana 59101 —
St. Vincent Healthcare Cancer Care Services Billings Montana 59101 —
Billings Clinic - Downtown Billings Montana 59107-7000 —
Bozeman Deaconess Cancer Center Bozeman Montana 59715 —
St. James Healthcare Cancer Care Butte Montana 59701 —
Big Sky Oncology Great Falls Montana 59405-5309 —
Great Falls Clinic - Main Facility Great Falls Montana 59405 —
Sletten Cancer Institute at Benefis Healthcare Great Falls Montana 59405 —
Not listed Great Falls Montana 59405 —
Northern Montana Hospital Havre Montana 59501 —
St. Peter's Hospital Helena Montana 59601 —
Glacier Oncology, PLLC Kalispell Montana 59901 —
Kalispell Medical Oncology at KRMC Kalispell Montana 59901 —
Kalispell Regional Medical Center Kalispell Montana 59901 —
Community Medical Center Missoula Montana 59801 —
Guardian Oncology and Center for Wellness Missoula Montana 59804 —
Montana Cancer Specialists at Montana Cancer Center Missoula Montana 59807-7877 —
Montana Cancer Center at St. Patrick Hospital and Health Sciences Center Missoula Montana 59807 —
Falck Cancer Center at Arnot Ogden Medical Center Elmira New York 14905 —
James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester New York 14642 —
Rutherford Hospital Rutherfordton North Carolina 28139 —
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195 —
Grandview Hospital Dayton Ohio 45405 —
Good Samaritan Hospital Dayton Ohio 45406 —
David L. Rike Cancer Center at Miami Valley Hospital Dayton Ohio 45409 —
Samaritan North Cancer Care Center Dayton Ohio 45415 —
CCOP - Dayton Dayton Ohio 45420 —
Blanchard Valley Medical Associates Findlay Ohio 45840 —
Middletown Regional Hospital Franklin Ohio 45005-1066 —
Wayne Hospital Greenville Ohio 45331 —
Cleveland Clinic Cancer Center Independence Ohio 44131 —
Charles F. Kettering Memorial Hospital Kettering Ohio 45429 —
UVMC Cancer Care Center at Upper Valley Medical Center Troy Ohio 45373-1300 —
Clinton Memorial Hospital Wilmington Ohio 45177 —
Cleveland Clinic - Wooster Wooster Ohio 44691 —
Ruth G. McMillan Cancer Center at Greene Memorial Hospital Xenia Ohio 45385 —
AnMed Cancer Center Anderson South Carolina 29621 —
CCOP - Upstate Carolina Spartanburg South Carolina 29303 —
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center Spartanburg South Carolina 29303 —
St. Joseph Cancer Center Bellingham Washington 98225 —
Olympic Hematology and Oncology Bremerton Washington 98310 —
Fred Hutchinson Cancer Research Center Seattle Washington 98104 —
Harborview Medical Center Seattle Washington 98104 —
Minor and James Medical, PLLC Seattle Washington 98104 —
Group Health Central Hospital Seattle Washington 98112 —
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus Seattle Washington 98122-4307 —
Polyclinic First Hill Seattle Washington 98122 —
University Cancer Center at University of Washington Medical Center Seattle Washington 98195-6043 —
Cancer Care Northwest - Spokane South Spokane Washington 99202 —
Evergreen Hematology and Oncology, PS Spokane Washington 99218 —
Rocky Mountain Oncology Casper Wyoming 82609 —
Welch Cancer Center at Sheridan Memorial Hospital Sheridan Wyoming 82801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00107380, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 7, 2016 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00107380 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →